CLINICAL_TRIALS
trial_result
· 2025-06-29
Clinical Trial Update: Study of ASN51 in Adults With Early Alzheimer's Disease [Phase 2]
Summary
A Phase 2 study of ASN51 for adults with early Alzheimer's disease was terminated, and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Asceneuron S.A. | Conditions: Alzheimer Disease | Phase 2 | Status: TERMINATED | Results posted: 2025-06-29